Modulation of host natural killer cell functions in breast cancer via prostaglandin E 2 receptors EP 2 and EP 4

Journal of Immunotherapy

Volumn 35, Issue 2, 2012, Pages 179-188

  Holt, Dawn M ^a   Ma, Xinrong ^b   Kundu, Namita ^a,b   Collin, Peter D ^d   Fulton, Amy M ^a,b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d Coastside Bio Resources ^*  (United States)

Author keywords

EP4; frondoside A; immunosuppression; NK cells; PGE 2

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; FRONDOSIDE A; GAMMA INTERFERON; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST METASTASIS; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; FEMALE; HOST CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SEPARATION; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84856888800     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0b013e318247a5e9     Document Type: Article

References (16)

1. Parhar R, Lala P. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J Leukoc Biol. 1988;44:474-484. (Pubitemid 19011718)
2. Baxevanis C, Reclos G, Gritzapis A, et al. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer. 1993; 72:491-501. (Pubitemid 23193457)
3. Kundu N, Yang Q, Dorsey R, et al. Increased cyclooxygenase- 2 (COX-2) expression and activity in a murine model of metastatic breast cancer. Int J Cancer. 2001;94:681-686. (Pubitemid 32695116)
4. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors. Physio Rev. 1999;79:1193-1226.
5. Kundu N, Ma X, Holt D, et al. Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function. Breast Cancer Res Treat. 2009;117:235-242.
6. Kundu N, Walser T, Ma X, et al. Cyclooxygenase inhibitors modulate NK activities that control metastatic disease. Cancer Immunol Immunother. 2005;54:981-987. (Pubitemid 41187706)
7. Ma X, Kundu N, Rifat S, et al. Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis. Cancer Res. 2006; 66:2923-2927.
8. Goldyne M, Stobo J. Prostaglandin E2 as a modulator of macrophage-T lymphocyte interactions. J Invest Dermatol. 1980;74:297-300. (Pubitemid 10034224)
9. Holt D, Ma X, Kundu N, et al. Prostaglandin E2 (PGE2) suppresses natural killer cell function through the PGE2 receptor EP4. Cancer Immunol, Immunother. 2011;60:1577-1586.
10. Wu Y, Zhou B. TNF-alpha/NF-KappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102:639-644.
11. Ma X, Kundu N, Collin P, et al. Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2. Breast Cancer Res Treat. 2011. [Epub July 15].
12. Elkashab M, Lala P. PGE2 receptors on murine splenic lymphocytes: Effects of tumor bearing. Immunol Lett. 1991;30:7-16.
13. Gray J, Roth BA. Last GASP for GPCRs? Science. 2002;297: 529-531.
14. Martinet L, Jean C, Dietrich G, et al. PGE2 inhibits natural killer and gd T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Biochem Pharmacol. 2010;80:838-845.
15. Su Y, Huang X, Raskovalova T, et al. Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression. Cancer Immunol Immunother. 2008 57 1611-1623.
16. Zeidler R, Csanady M, Gires O, et al. Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1. FASEB J. 2000;14:661-668. (Pubitemid 30198565)